Home » Market News » DirectorsTalk Highlights » A dozen years of clinical trials performing advanced cell therapy with perinatal cells
WideCells Group PLC

A dozen years of clinical trials performing advanced cell therapy with perinatal cells

Since we published our article, ‘The first decade of advanced cell therapy clinical trials using perinatal cells (2005–2015)’, we have continued to gather data on cell and gene therapy clinical trials, and we can now report on trends in perinatal cell therapy for the years 2005–2017.

‘Cumulatively from 2005 through 2017 there are a total of 131 advanced cell therapy clinical trials with cells unique to cord blood. Among these trials, 75% of the indications for use are either hematology/oncology (39%), or neurology (36%).’

 

WideCells Group PLC (LON:WDC) is building an integrated stem cell services company, focused on making stem cell treatments both accessible and affordable.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.